Latest News about APLS
Recent news which mentions APLS
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
October 29, 2024
From Motley Fool
Navigating 18 Analyst Ratings For Apellis Pharmaceuticals
October 16, 2024
Tickers
APLS
From Benzinga
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
From Benzinga
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Monday
September 23, 2024
From Benzinga
What's Going With Apellis Pharmaceuticals Stock Friday?
September 20, 2024
From Benzinga
Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals
September 13, 2024
Tickers
APLS
From Benzinga
From InvestorPlace
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
August 08, 2024
From Benzinga
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
August 02, 2024
Tickers
APLS
From Benzinga
From Benzinga
Tickers
APLS
From InvestorPlace
From Benzinga
From Benzinga
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
March 27, 2024
Tickers
APLS
From Benzinga
Peering Into Apellis Pharmaceuticals's Recent Short Interest
March 15, 2024
Tickers
APLS
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years
February 22, 2024
From Benzinga
$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
February 05, 2024
From Benzinga
From Benzinga
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
January 30, 2024
Tickers
APLS
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.